Intelligence

Best Supplement for Melasma

Which supplements have real evidence for melasma — and why no pill works without daily sun protection. An honest guide to fading it from within.

21 · 06 · 2026 12 min readBy Jaouad Bentaguena
Best supplements for melasma
In brief

Which supplements have real evidence for melasma — and why no pill works without daily sun protection. An honest guide to fading it from within.

The short answer: there is no single supplement that “cures” melasma. The most useful non-prescription oral strategy is one that supports pigmentation biology with human evidence, while daily broad-spectrum photoprotection remains the foundation. For RADIANCE, the strongest directly relevant evidence comes from BELIGHT³™ — a defined grape, licorice and vitamin C complex studied in two randomized, double-blind, placebo-controlled trials on facial dark spots and hyperpigmentation — together with oral glutathione and antioxidant support. The important caveat: those BELIGHT³™ trials were not melasma trials, so RADIANCE should be positioned as an adjunct for melasma, not a replacement for sunscreen or dermatologic treatment.

If you are searching for the best supplement for melasma, the useful question is not “which single ingredient wins?” Melasma is chronic, recurrent and driven by several pathways at once: UV, visible light, hormonal signalling, oxidative stress, inflammation and melanocyte activity.

That is why a good oral formula should be judged on three things:

  1. Does it contain ingredients with human pigmentation data?
  2. Does its mechanism make sense for melanin production and oxidative signalling?
  3. Is it clearly positioned as an adjunct to photoprotection and topical care?

Melasma is not just a “dark spot”

Melasma is a chronic hyperpigmentation disorder that usually appears as symmetrical brown or grey-brown patches on the cheeks, forehead, upper lip or jawline. It is biologically different from a solar lentigo or a post-acne mark.

That distinction matters because evidence from a study on facial dark spots or solar hyperpigmentation is highly relevant to pigment biology, but it should not automatically be relabelled as evidence for diagnosed melasma.

The foundation: UV and visible-light protection

Melasma is easily re-triggered by light. Daily broad-spectrum sunscreen is therefore not optional.

For melasma and other pigmentation-prone conditions, visible light also matters. Clinical trials have shown that tinted sunscreens containing iron oxides can improve pigment-control outcomes compared with UV-only sunscreen, especially in darker phototypes.

No supplement out-works the trigger. If light keeps stimulating pigment, every other intervention is working uphill.

This is why RADIANCE is best used as a systemic layer alongside daily photoprotection, not instead of it.

What should you look for in a melasma supplement?

The strongest commercial mistake in this category is to equate “many antioxidants” with “evidence.” The better approach is to separate ingredients by the quality of data behind them.

Ingredient / system Evidence level Why it matters
BELIGHT³™ Two randomized placebo-controlled human pigmentation trials Direct evidence on facial dark spots / hyperpigmentation
Oral glutathione Several controlled pigmentation studies; mixed quality overall Relevant to oxidative stress and melanogenesis
Vitamin C Strong biological rationale; less direct evidence alone Antioxidant support and melanogenesis-related chemistry
Grape + licorice polyphenols Strongest when considered as the defined BELIGHT³™ combination Tyrosinase-related and antioxidant pathways
Maritime pine bark Antioxidant and ingredient-level rationale Supports oxidative-stress defence within a broader formula
L-cystine + selenium Supporting biochemical rationale Relevant to endogenous glutathione biology

1. BELIGHT³™: the strongest direct evidence in RADIANCE

BELIGHT³™ combines grape-seed extract, grape-pomace extract, licorice root extract and coated vitamin C.

Its strength is that the evidence is not limited to a theoretical antioxidant mechanism.

In the first randomized, double-blind, placebo-controlled study, 58 Asian adults aged 45–65 with facial dark spots were randomized to BELIGHT³™ or placebo for 12 weeks. Fifty-three completed the study. Instrumental measurements showed significantly greater skin-lightening effects with the active formulation, and existing dark spots showed measurable improvement.

A second randomized, double-blind, placebo-controlled study published in 2025 enrolled 66 Caucasian adults with facial hyperpigmentation. After 12 weeks, instrumental dark-spot lightness measures and clinical assessments of complexion evenness and dark-spot visibility favoured BELIGHT³™ over placebo.

That gives BELIGHT³™ a meaningful place in a pigmentation formula.

The caveat matters just as much: these were dark-spot / hyperpigmentation studies, not melasma trials.

What about the 84.9% tyrosinase figure?

In a laboratory experiment, the botanical combination used in BELIGHT³™ produced 84.9% tyrosinase inhibition in vitro, greater than the individual extracts tested separately.

That is mechanistic evidence. It is not an 84.9% reduction in human melasma or dark spots.

This distinction is important because in-vitro enzyme inhibition and clinical pigmentation change are different evidence levels.

2. Oral glutathione: promising, but not a magic “whitening” ingredient

Glutathione is involved in cellular antioxidant defence and has been studied for pigmentation outcomes.

A 2025 systematic review identified multiple randomized oral-glutathione studies. Several reported reductions in melanin index compared with placebo, but overall study quality was mixed.

That supports glutathione as a credible pigmentation ingredient, while still leaving room for uncertainty around the best form, amount and long-term effect.

It is also too simplistic to say that standard oral glutathione “does not absorb” and that liposomal delivery automatically solves the problem. Liposomal delivery may alter pharmacokinetics, but better delivery should not be confused with proven superior melasma outcomes unless it has been shown clinically.

3. Vitamin C: important support, but not the hero alone

Vitamin C has antioxidant activity and can influence melanogenesis-related chemistry, including reactions involving the copper-containing enzyme tyrosinase.

But oral vitamin C alone has much weaker clinical evidence for melasma than its popularity suggests.

Its stronger role is as part of a broader pigmentation architecture — especially when combined with polyphenols and antioxidant systems rather than positioned as a stand-alone melasma treatment.

For the detailed evidence hierarchy, see does vitamin C fade dark spots?

4. Grape and licorice polyphenols: combination evidence matters

Grape and licorice compounds have relevant antioxidant and melanogenesis-related mechanisms, but the most useful clinical evidence comes from the defined BELIGHT³™ formulation.

That is more meaningful than saying “grape seed works” or “licorice works” in isolation.

A study on a defined combination validates that combination. It does not automatically validate every capsule containing one of the same plants.

5. Maritime pine bark: supporting antioxidant architecture

Maritime pine bark is rich in oligomeric proanthocyanidins and fits naturally into an antioxidant pigmentation formula.

Its strongest role in this article is as supporting antioxidant architecture, not as the main melasma claim. That keeps the hierarchy clear: BELIGHT³™ carries the most directly relevant pigmentation evidence inside RADIANCE.

6. L-cystine and selenium: support the glutathione pathway

L-cystine is relevant to cysteine availability and endogenous glutathione synthesis, while selenium is required by glutathione-peroxidase enzymes.

These are legitimate biochemical relationships, but they should be presented as supporting pathway logic, not as stand-alone clinical melasma treatments.

What about prescription oral treatments?

If melasma is persistent or severe, supplements are not the strongest oral intervention available.

Oral tranexamic acid has substantially more melasma-specific clinical evidence than most supplements, but it is a prescription medication used off-label and requires medical screening because of contraindications and thromboembolic risk.

That is why a serious supplement article should acknowledge its limits: supplements can be useful adjuncts, but they do not replace dermatologic treatment when stronger therapy is appropriate.

So what is the best supplement strategy for melasma?

If you want a non-prescription oral approach, I would use this framework:

  1. Photoprotection first. Broad-spectrum sunscreen daily; for melasma, consider tinted iron-oxide protection against visible light.
  2. Choose a formula with direct human pigmentation evidence. Avoid products built only around long ingredient lists.
  3. Prefer a multi-pathway architecture. Pigment biology involves oxidative stress, melanogenesis signalling and recurrent light exposure.
  4. Keep diagnosis-specific expectations. Dark-spot evidence is relevant to melasma, but it is not the same thing as a melasma trial.
  5. Use oral support as an adjunct. Persistent melasma deserves topical and, when needed, medical treatment.
THE PIGMENT RESPONSE
RADIANCE

Pigment · Signal · Oxidative Stress

RADIANCE is built as a systemic pigmentation architecture: BELIGHT³™ for its randomized dark-spot data, a glutathione pathway, and antioxidant support designed to complement daily photoprotection and topical care.

Explore the RADIANCE architecture

Why RADIANCE takes this approach

RADIANCE is not built around a single “melasma ingredient.” It is built around the broader pigment system.

The formulation combines:

  • BELIGHT³™ — grape seed, grape pomace, licorice and coated vitamin C, supported by two randomized placebo-controlled human pigmentation trials;
  • glutathione — within a broader glutathione-pathway architecture;
  • L-cystine and selenium — for supporting endogenous glutathione biology;
  • maritime pine bark — as part of the antioxidant network;
  • curcumin + BioPerine® — included within the oxidative-stress architecture.

The central evidence distinction remains:

  • BELIGHT³™ has two human randomized pigmentation trials.
  • Those trials were not melasma trials.
  • Ingredient studies are not finished-product RADIANCE trials.

That is why RADIANCE is best framed as a systemic pigmentation Protocol that can sit inside a melasma strategy, rather than as a product that claims to cure melasma.

How long should you give a melasma supplement?

Most relevant oral pigmentation studies assess outcomes over approximately 8–12 weeks.

That does not mean melasma is “fixed” after three months. Melasma is chronic and relapses easily, so maintenance photoprotection matters long after the study window ends.

Melasma supplements in Singapore, Hong Kong and Japan

Melasma is particularly relevant across Singapore, Hong Kong and Japan, where cumulative light exposure and Asian skin phototypes make pigmentation a major beauty and dermatology concern.

For consumers in these markets, three things matter:

  • Use daily high-level photoprotection. In Singapore and Hong Kong especially, year-round UV exposure makes consistency critical.
  • Consider visible-light protection. Tinted iron-oxide sunscreen can be especially useful for melasma-prone skin.
  • Check exact ingredient equivalence. A product should not claim another brand’s clinical trial simply because it contains a similar plant or antioxidant.

The first BELIGHT³™ trial is relevant to Asian consumers because it specifically enrolled Asian adults with facial dark spots. Importantly, participants with melasma identified during screening were excluded, which is precisely why the study should be described as dark-spot evidence rather than melasma evidence.

Frequently asked questions

What is the best supplement for melasma?

There is no universally proven best supplement. A useful non-prescription approach is to choose a formula with controlled human pigmentation data, combined with antioxidant and melanogenesis-related support, while using daily broad-spectrum and visible-light-aware photoprotection. RADIANCE uses this architecture through BELIGHT³™, glutathione-pathway support and antioxidants.

Does RADIANCE treat melasma?

RADIANCE is designed for pigmentation and uneven tone, but it has not been clinically tested as a treatment for diagnosed melasma. Its central BELIGHT³™ active has randomized human evidence for facial dark spots and hyperpigmentation. For melasma, RADIANCE should be considered an adjunct to photoprotection and appropriate dermatologic care.

Does glutathione help melasma?

Several controlled oral glutathione studies have reported reductions in melanin index, and a 2025 systematic review found promising but mixed-quality evidence. Glutathione is not a cure for melasma, and intravenous glutathione should not be used for cosmetic skin lightening.

Is liposomal glutathione better for melasma?

Liposomal delivery may alter absorption, but better pharmacokinetics are not automatically proof of better melasma outcomes. Comparative clinical evidence would be needed to establish superiority.

Does vitamin C help melasma?

Vitamin C has antioxidant and melanogenesis-related biology, but oral vitamin C alone has limited direct melasma evidence. Its stronger role is as part of a broader pigmentation formula rather than as a stand-alone treatment.

What sunscreen is best for melasma?

Use high broad-spectrum UV protection every day. For melasma, tinted sunscreen containing iron oxides can add visible-light protection, which has clinical evidence for improving pigmentation-control outcomes compared with UV-only sunscreen.

How long do melasma supplements take to work?

Most oral pigmentation studies assess changes over about 8–12 weeks. Melasma is chronic and relapsing, so ongoing photoprotection matters more than treating three months as a permanent endpoint.

Can melasma be cured permanently?

Melasma is usually considered chronic and relapse-prone. It can often be improved and controlled, but recurrence is common when light exposure, hormones or other triggers persist.

Is oral tranexamic acid a supplement for melasma?

No. Tranexamic acid is a prescription medication used off-label for melasma under medical supervision. It has stronger melasma-specific evidence than most supplements but requires screening for contraindications and thromboembolic risk.

Which SKINĒDIT Protocol is for pigmentation?

RADIANCE is the SKINĒDIT Protocol for visible pigmentation, dark spots and uneven tone. Its architecture combines BELIGHT³™, glutathione-pathway support and antioxidants, and it is designed to complement sunscreen and topical pigment care.

Related reading

References

Pouchieu C, Pourtau L, Gaudout D, et al. Effect of an oral formulation on skin lightening: results from in vitro tyrosinase inhibition to a double-blind randomized placebo-controlled clinical study in healthy Asian participants. Cosmetics. 2023;10(5):143.

Tursi F, Pourtau L, Roveda G, et al. Clinical efficacy of BELIGHT³™ on dark spot pigmentation in Caucasian subjects. Cosmetics. 2025;12(1):27.

Sarkar R, Yadav V, Yadav T, et al. Glutathione as a skin-lightening agent and in melasma: a systematic review. International Journal of Dermatology. 2025;64(6):992–1004.

Castanedo-Cazares JP, Hernández-Blanco D, Carlos-Ortega B, et al. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial. Photodermatology, Photoimmunology & Photomedicine. 2014;30(1):35–42.

Liang R, Luo H, Pan W, et al. Comparative efficacy and safety of tranexamic acid for melasma by different administration methods: a systematic review and network meta-analysis. Journal of Cosmetic Dermatology. 2024;23(4):1150–1164.

Evidence note: BELIGHT³™ has randomized human evidence for facial dark spots and hyperpigmentation, not diagnosed melasma. The 84.9% tyrosinase-inhibition figure is an in-vitro enzyme result, not a percentage reduction in human pigmentation. Ingredient studies are not finished-product RADIANCE trials. RADIANCE should be positioned as systemic pigmentation support, not as a replacement for sunscreen, prescription treatment or dermatologic assessment.

Jaouad Bentaguena
Written byJaouad BentaguenaFounder, SKĪNĒDIT Paris

Jaouad Bentaguena is the founder of SKINĒDIT Paris. He researches and writes the SKINĒDIT's Intelligence journal himself — working from the peer-reviewed literature and alongside the scientists and clinical partners behind each protocol, to translate the science of deep skincare into something clear enough to act on.

About the author
Continue reading
Back to Intelligence